-
1
Beta-hydroxy-beta-methylbutyrate (HMB) improves daily activity and whole-body protein metabolism in Duchenne muscular dystrophy dogs: a pilot study
Published 2025-02-01Subjects: Get full text
Article -
2
Binding of LncDACH1 to dystrophin impairs the membrane trafficking of Nav1.5 protein and increases ventricular arrhythmia susceptibility
Published 2025-01-01Subjects: Get full text
Article -
3
-
4
Inhibition of hippocampal interleukin-6 receptor-evoked signalling normalises long-term potentiation in dystrophin-deficient mdx mice
Published 2025-02-01Subjects: Get full text
Article -
5
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
Published 2025-03-01Subjects: Get full text
Article -
6
A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophy
Published 2025-02-01Subjects: Get full text
Article -
7
-
8
Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy
Published 2024-12-01Subjects: “…brain dystrophin…”
Get full text
Article -
9
Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
Published 2024-12-01Subjects: Get full text
Article -
10
抗肌萎缩蛋白基因缺失热区50号和51号内含子的克隆和测序
Published 1993-01-01Subjects: “…抗肌萎缩蛋白基因(dystrophin基因)…”
Get full text
Article -
11
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy
Published 2025-01-01Subjects: Get full text
Article